How to buy Aditxt stock (ADTX)

Aditxt is a biotechnology business based in the US. Aditxt shares (ADTX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.19 – a decrease of 46.55% over the previous week. Aditxt employs 47 staff and has a trailing 12-month revenue of around $329,739.

Our top picks for where to buy Aditxt stock

Buy Aditxt stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Aditxt stock price (NASDAQ: ADTX)

Use our graph to track the performance of ADTX stocks over time.

Aditxt shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$0.19
52-week range	$0.22 - $338.80
50-day moving average more info button	$0.58
200-day moving average more info button	$52.77
Wall St. target price	$61.00
PE ratio more info button	0.0004
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$628.80

Is it a good time to buy Aditxt stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aditxt price performance over time

Historical closes compared with the close of $0.1861 from 2024-12-20

1 week (2024-12-13)	-46.55%
1 month (2024-11-22)	-45.09%
3 months (2024-09-20)	-51.36%
6 months (2024-06-21)	-86.71%

1 year (2023-12-22)	-95.91%
2 years (2022-12-22)	-99.61%
3 years (2021-12-22)	26.072
5 years (2019-12-18)	N/A

Is Aditxt stock undervalued or overvalued?

Valuing Aditxt stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aditxt's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Aditxt's P/E ratio

Aditxt's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Aditxt shares trade at around 0x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Aditxt financials

Revenue TTM	$329,739
Gross profit TTM	$166,936
Return on assets TTM	-117.61%
Return on equity TTM	-3493.63%
Profit margin	0%
Book value	$486.96
Market Capitalization more info button	$3.4 million

TTM: trailing 12 months

Aditxt share dividends

We're not expecting Aditxt to pay a dividend over the next 12 months.

Have Aditxt's shares ever split?

Aditxt's shares were split on a 1:40 basis on 1 October 2024 . So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aditxt shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Aditxt shares which in turn could have impacted Aditxt's share price.

Aditxt share price volatility

Over the last 12 months, Aditxt's shares have ranged in value from as little as $0.22 up to $338.8. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aditxt's is 1.081. This would suggest that Aditxt's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Aditxt overview

Aditxt, Inc. , a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc.

Frequently asked questions

null
What percentage of Aditxt is owned by insiders or institutions?
Currently 0.012% of Aditxt shares are held by insiders and 0.253% by institutions. How many people work for Aditxt?
Latest data suggests 47 work at Aditxt. When does the fiscal year end for Aditxt?
Aditxt's fiscal year ends in December. Where is Aditxt based?
Aditxt's address is: 737 North Fifth Street, Richmond, VA, United States, 23219 What is Aditxt's ISIN number?
Aditxt's international securities identification number is: US0070251097